27 May 2022: Clinical Research
Factors Associated with Falls During Hospitalization for Coronavirus Disease 2019 (COVID-19)
Marcin Mikos 1ABCDE* , Błażej Szydło 2BCE , Ivan Szergyuk 3CDEF , Maria Helena Santos de Oliveira 4BCD , Michał Kuboń 2BCD , Grzegorz Juszczyk 5AE , Brandon Michael Henry 6CEDOI: 10.12659/MSM.936547
Med Sci Monit 2022; 28:e936547
Table 2 Circulating biomarkers measured in total sample of COVID-19 patients and stratified by whether the patient fell.
| Variable | Total sample | No fall | Fall | p-value |
|---|---|---|---|---|
| CRP, mg/L | 51.7 (13.3–107.5) | 49.7 (13.1–107.6) | 87.9 (58.8–97.5) | 0.343 |
| Procalcitonin, ng/mL | 0.07 (0.03–0.19) | 0.07 (0.03–0.19) | 0.04 (0.037–0.07) | 0.427 |
| D-dimers, μgFEU/nL | 1.21 (0.57–2.50) | 1.20 (0.57–2.50) | 1.32 (0.97–2.60) | 0.695 |
| WBC count, 10/μL | 7.55 (5.54–10.53) | 7.53 (5.58–10.35) | 11.30 (5.01–11.90) | 0.701 |
| Lymphocyte count, 10/μL | 1.17 (0.76–1.76) | 1.16 (0.76–1.75) | 2.29 (1–2.96) | 0.173 |
| TSH, μIU/mL | 1.00 (0.48–1.94) | 0.97 (0.47–1.93) | 5.3 (3.71–5.51) | |
| CK, μmol/L | 73.8 (41.0–218.7) | 71.7 (37.4–208.0) | 288.5 (181.1–384.8) | 0.102 |
| ALT, IU/L | 33.1 (19.1–59.1) | 33.5 (20.2–59.4) | 17.1 (16.4–21.5) | |
| AST, IU/L | 33.7 (23.2–54.5) | 34.0 (23.3–55.0) | 29.8 (21.6–30.3) | 0.287 |
| All data presented as median (IQR), with P-values calculated using Mann-Whitney’s U test. CRP – C reactive protein; WBC – white blood cells; TSH – thyroid stimulating hormone; CK – creatinine kinase; ALT – alanine aminotransferase; AST – aspartate aminotransferase. Statistical significance denoted with bold text. | ||||